AOD targets fat-burning without impacting blood sugar or growth hormone levels
IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
Representative sources include peer-reviewed publications indexed by PubMed and scientific literature describing 5-Amino-1MQ, NNMT pathway research, metabolic physiology, cellular energy regulation, and adipocyte biology
Lost 12 pounds since the started the product
Both treatments are expertly administered by our Southampton skincare experts, ensuring natural and long-lasting results
Researchers utilize AOD9604 to examine how specific regions of growth hormone influence lipid metabolism independently of growth hormone receptor-mediated effects in experimental models of obesity and metabolic disorders